Jpmorgan Chase & CO Heron Therapeutics, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 206,711 shares of HRTX stock, worth $316,267. This represents 0.0% of its overall portfolio holdings.

Number of Shares
206,711
Previous 52,224 295.82%
Holding current value
$316,267
Previous $182,000 125.82%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 26, 2024
BUY
$1.73 - $3.67 $267,262 - $566,967
154,487 Added 295.82%
206,711 $411,000
Q3 2024

Nov 08, 2024
BUY
$1.73 - $3.67 $267,262 - $566,967
154,487 Added 295.82%
206,711 $411,000
Q2 2024

Dec 26, 2024
SELL
$2.32 - $3.86 $358,409 - $596,319
-154,487 Reduced 74.74%
52,224 $182,000
Q2 2024

Aug 12, 2024
BUY
$2.32 - $3.86 $22,596 - $37,596
9,740 Added 22.93%
52,224 $182,000
Q1 2024

Dec 26, 2024
SELL
$1.71 - $3.06 $280,828 - $502,534
-164,227 Reduced 79.45%
42,484 $117,000
Q1 2024

May 10, 2024
SELL
$1.71 - $3.06 $56,664 - $101,399
-33,137 Reduced 43.82%
42,484 $117,000
Q4 2023

Dec 26, 2024
SELL
$0.54 - $1.82 $70,788 - $238,583
-131,090 Reduced 63.42%
75,621 $128,000
Q4 2023

Feb 12, 2024
SELL
$0.54 - $1.82 $3.64 Million - $12.3 Million
-6,734,321 Reduced 98.89%
75,621 $128,000
Q3 2023

Nov 14, 2023
SELL
$0.97 - $1.8 $44,298 - $82,204
-45,669 Reduced 0.67%
6,809,942 $7.01 Million
Q2 2023

Aug 11, 2023
SELL
$1.11 - $2.88 $256,609 - $665,798
-231,180 Reduced 3.26%
6,855,611 $7.95 Million
Q1 2023

May 18, 2023
BUY
$1.51 - $3.25 $119,043 - $256,220
78,837 Added 1.12%
7,086,791 $10.7 Million
Q1 2023

May 11, 2023
BUY
$1.51 - $3.25 $383,472 - $825,353
253,955 Added 3.76%
7,007,954 $10.6 Million
Q4 2022

Feb 13, 2023
BUY
$2.25 - $4.67 $133,458 - $277,001
59,315 Added 0.89%
6,753,999 $16.9 Million
Q3 2022

Nov 14, 2022
SELL
$2.66 - $5.37 $508,041 - $1.03 Million
-190,993 Reduced 2.77%
6,694,684 $28.3 Million
Q2 2022

Aug 11, 2022
BUY
$2.3 - $6.29 $1.75 Million - $4.78 Million
759,541 Added 12.4%
6,885,677 $19.2 Million
Q1 2022

May 11, 2022
SELL
$4.63 - $9.94 $595,556 - $1.28 Million
-128,630 Reduced 2.06%
6,126,136 $35 Million
Q4 2021

Feb 10, 2022
BUY
$8.35 - $12.6 $7.96 Million - $12 Million
952,969 Added 17.97%
6,254,766 $57.1 Million
Q3 2021

Nov 12, 2021
BUY
$10.13 - $15.0 $53.7 Million - $79.5 Million
5,301,797 New
5,301,797 $56.7 Million

Others Institutions Holding HRTX

# of Institutions
179
Shares Held
121M
Call Options Held
80.4K
Put Options Held
94.9K
View Full List

About HERON THERAPEUTICS, INC.

HRTX Quotes by TradingView
  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $182M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email